LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Argos Therapeutics Inc.
Headquarters:
Durham, NC, United States
Website:
N/A
Year Founded:
1997
Status:
Acquired
BioCentury
|
Oct 26, 2022
Deals
LG’s Aveo acquisition a rare case of a Korean biotech buying a U.S. biotech
With Aveo, LG gets an FDA-approved product and U.S.-based commercialization and regulatory expertise
Read More
BioCentury
|
Sep 2, 2021
Management Tracks
Novo Ventures’ Lüneborg joins Forbion
Nallicheri ascends to CEO at EQRx, plus: Hummingbird’s new CFO, Acadia, Pillar, Ribon and more
Read More
BioCentury
|
Jul 23, 2020
Emerging Company Profile
Elevation debuts with tumor-agnostic mAb in Phase II
Elevation Oncology’s lead program is in development for NRG1 fusion-driven solid tumors
Read More
BioCentury
|
Feb 22, 2019
Company News
SCM, Genexine purchase Argos
Read More
BioCentury
|
Dec 13, 2018
Company News
Management tracks: Tamura reclaims CEO role at Sosei
Read More
BioCentury
|
May 19, 2017
Clinical News
FDA agrees with Argos' decision to continue Phase III of rocapuldencel-T
Read More
BioCentury
|
Apr 21, 2017
Clinical News
Rocapuldencel-T: Additional Ph III ADAPT data
Read More
BioCentury
|
Apr 14, 2017
Company News
Management tracks
Read More
BioCentury
|
Apr 7, 2017
Finance
Fade to black
Biotech winners, losers in 1Q17
Read More
BioCentury
|
Feb 24, 2017
Clinical News
Rocapuldencel-T: Ph III ADAPT data
Read More
Items per page:
10
1 - 10 of 103
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help